Inactive Instrument
Biondvax Pharmaceuticals Ltd Stock Other OTC
Stocks
Biotechnology & Medical Research
| Manager | Title | Age | Since |
|---|---|---|---|
Amir Reichman
CEO | Chief Executive Officer | 51 | 02/03/2021 |
Uri Ben-Or
DFI | Director of Finance/CFO | 55 | 01/01/2007 |
Dalit Fischer
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Mark Germain
CHM | Chairman | 77 | 30/09/2019 |
Samuel Moed
BRD | Director/Board Member | 64 | 24/03/2020 |
Adi Raviv
BRD | Director/Board Member | 71 | 24/03/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 38.98M | |
| -0.88% | -2.60% | -1.51% | +14.05% | 48.93B | |
| -0.40% | +1.03% | +418.57% | +527.30% | 45.01B | |
| -1.42% | +2.30% | +42.67% | +22.37% | 44.07B | |
| -1.22% | -2.31% | +4.82% | +77.49% | 40.73B | |
| -0.96% | -2.31% | +15.75% | +45.41% | 33.52B | |
| -0.21% | +9.14% | - | - | 17.77B | |
| -0.35% | -1.56% | +21.42% | +120.75% | 16.5B | |
| -1.60% | -1.32% | +11.98% | +31.10% | 14.67B | |
| -1.65% | -1.03% | +75.93% | +41.12% | 13.77B | |
| Average | -0.87% | +0.48% | +73.70% | +109.95% | 30.55B | |
| Weighted average by Cap. | -0.95% | +0.05% | +89.21% | +128.70% |
